Hologic EBITDA 2006-2018 | HOLX
Current and historical ebitda for Hologic (HOLX) from 2006 to 2018. Ebitda can be defined as income before interest, taxes, depreciation and amortization. Hologic ebitda for the twelve months ending June 30, 2018 was $0.254B. Hologic ebitda for the three months ending June 30, 2018 was $0.254B, representing a 8.7% increase from the same quarter last year.
| Hologic Annual EBITDA (Millions of US $) |
|
|---|---|
| 2017 | $1,819 |
| 2016 | $1,014 |
| 2015 | $947 |
| 2014 | $803 |
| 2013 | $727 |
| 2012 | $465 |
| 2011 | $679 |
| 2010 | $441 |
| 2009 | $597 |
| 2008 | $-25 |
| 2007 | $179 |
| 2006 | $66 |
| 2005 | $40 |
| Hologic Quarterly EBITDA (Millions of US $) |
|
|---|---|
| Q3 2018 | $254 |
| Q2 2018 | $-485 |
| Q1 2017 | $255 |
| Q4 2017 | $230 |
| Q3 2017 | $233 |
| Q2 2017 | $1,095 |
| Q1 2016 | $261 |
| Q4 2016 | $262 |
| Q3 2016 | $260 |
| Q2 2016 | $250 |
| Q1 2015 | $242 |
| Q4 2015 | $248 |
| Q3 2015 | $237 |
| Q2 2015 | $236 |
| Q1 2014 | $226 |
| Q4 2014 | $223 |
| Q3 2014 | $210 |
| Q2 2014 | $180 |
| Q1 2013 | $189 |
| Q4 2013 | $214 |
| Q3 2013 | $190 |
| Q2 2013 | $132 |
| Q1 2012 | $191 |
| Q4 2012 | $77 |
| Q3 2012 | $157 |
| Q2 2012 | $87 |
| Q1 2011 | $144 |
| Q4 2011 | $152 |
| Q3 2011 | $151 |
| Q2 2011 | $231 |
| Q1 2010 | $145 |
| Q4 2010 | $6 |
| Q3 2010 | $153 |
| Q2 2010 | $136 |
| Q1 2009 | $146 |
| Q4 2009 | $146 |
| Q3 2009 | $150 |
| Q2 2009 | $141 |
| Q1 2008 | $160 |
| Q4 2008 | $-43 |
| Q3 2008 | $153 |
| Q2 2008 | $151 |
| Q1 2007 | $-286 |
| Q4 2007 | $54 |
| Q3 2007 | $48 |
| Q2 2007 | $42 |
| Q1 2006 | $35 |
| Q4 2006 | $15 |
| Q3 2006 | $22 |
| Q2 2006 | $19 |
| Q1 2005 | $10 |
| Q4 2005 | $13 |
| Q3 2005 | $11 |
| Q2 2005 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.686B | $3.059B |
| Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $93.292B | 22.38 |
| Intuitive Surgical (ISRG) | United States | $60.172B | 57.44 |
| Fresenius Medical Care (FMS) | Germany | $29.566B | 20.88 |
| Edwards Lifesciences (EW) | United States | $28.713B | 32.34 |
| IDEXX Laboratories (IDXX) | United States | $21.074B | 64.04 |
| ABIOMED (ABMD) | United States | $16.661B | 136.49 |
| DexCom (DXCM) | United States | $11.259B | 0.00 |
| Teleflex (TFX) | United States | $10.580B | 25.17 |
| Varian Medical Systems (VAR) | United States | $10.133B | 25.50 |
| STERIS (STE) | United Kingdom | $9.685B | 26.64 |
| LivaNova (LIVN) | United Kingdom | $6.004B | 35.81 |
| Masimo (MASI) | United States | $5.810B | 38.69 |
| Integra LifeSciences Holdings (IART) | United States | $5.322B | 27.54 |
| Globus Medical (GMED) | United States | $5.155B | 34.29 |
| Inogen (INGN) | United States | $4.937B | 130.64 |
| Penumbra (PEN) | United States | $4.217B | 383.28 |
| Cantel Medical (CMD) | United States | $3.981B | 41.50 |
| Opko Health (OPK) | United States | $3.012B | 0.00 |
| Halyard Health (AVNS) | United States | $2.991B | 24.61 |
| Wright Medical Group (WMGI) | Netherlands | $2.954B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.228B | 20.17 |
| Nevro (NVRO) | United States | $1.917B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.782B | 0.00 |
| AxoGen (AXGN) | United States | $1.412B | 0.00 |
| Glaukos (GKOS) | United States | $1.412B | 809.00 |
| Natus Medical (BABY) | United States | $1.246B | 26.42 |
| Accelerate Diagnostics (AXDX) | United States | $1.242B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.210B | 0.00 |
| Luminex (LMNX) | United States | $1.205B | 35.55 |
| CryoLife (CRY) | United States | $1.180B | 103.55 |
| Tactile Systems Technology (TCMD) | United States | $1.064B | 181.38 |
| TransEnterix (TRXC) | United States | $0.905B | 0.00 |
| K2Ms (KTWO) | United States | $0.876B | 0.00 |
| Intersect ENT (XENT) | United States | $0.824B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.791B | 29.38 |
| Mesa Laboratories (MLAB) | United States | $0.785B | 48.57 |
| ViewRay (VRAY) | United States | $0.743B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.598B | 0.00 |
| Sientra (SIEN) | United States | $0.596B | 0.00 |
| Neuronetics (STIM) | United States | $0.544B | 0.00 |
| Veracyte (VCYT) | United States | $0.416B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.412B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.399B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.375B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.366B | 0.00 |
| Accuray (ARAY) | United States | $0.310B | 0.00 |
| IRadimed (IRMD) | United States | $0.304B | 109.61 |
| RTI Surgical (RTIX) | United States | $0.295B | 58.13 |
| T2 Biosystems (TTOO) | United States | $0.290B | 0.00 |
| Fluidigm (FLDM) | United States | $0.280B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.258B | 32.27 |
| Nuvectra (NVTR) | United States | $0.255B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.246B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.227B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.203B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.176B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.171B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.165B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.138B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.096B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.095B | 0.00 |
| EDAP TMS (EDAP) | France | $0.091B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.082B | 0.00 |
| Invuity (IVTY) | United States | $0.081B | 0.00 |
| Neovasc (NVCN) | Canada | $0.066B | 0.00 |
| ConforMIS (CFMS) | United States | $0.059B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.043B | 23.36 |
| Vermillion (VRML) | United States | $0.039B | 0.00 |
| Presbia (LENS) | Ireland | $0.036B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.032B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.029B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.028B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.025B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.024B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.024B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.019B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.018B | 14.09 |
| Bioanalytical Systems (BASI) | United States | $0.013B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.010B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.006B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| Amedica (AMDA) | United States | $0.002B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.001B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
